Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study von Friday, Bret B, Anderson, S Keith, Buckner, Jan, Yu, Chunrong, Giannini, Caterina, Geoffroy, Francois, Schwerkoske, John, Mazurczak, Miroslaw, Gross, Howard, Pajon, Eduardo, Jaeckle, Kurt, Galanis, Evanthia

Volltext

Phase II trial of gemcitabine and docetaxel in patients with advanced carcinoma of the urothelium: A trial of the eastern cooperative oncology group von DREICER, Robert, MANOLA, Judith, SCHNEIDER, Daniel J, SCHWERKOSKE, John F, GEORGE, Christopher S, ROTH, Bruce J, WILDING, George

Volltext

New multi-component reaction accessing 3-aminoimidazo[1,2- a]pyridines von Schwerkoske, John, Masquelin, Thierry, Perun, Tom, Hulme, Christopher

Volltext

Sequential Ugi/Strecker reactions via microwave assisted organic synthesis: novel 3-center-4-component and 3-center-5-component multi-component reactions von Masquelin, Thierry, Bui, Hai, Brickley, Bob, Stephenson, Gregory, Schwerkoske, John, Hulme, Christopher

Volltext

201P Trilaciclib combined with sacituzumab govitecan (SG) in metastatic triple-negative breast cancer (mTNBC): Preliminary phase II results von Seneviratne, L., Harnden, K.K., Mardones, M., Blau, S., Gillespie-Twardy, A., Danso, M.A., Berz, D., Guaqueta, D., Schwerkoske, J., O'Shaughnessy, J., Patt, D., Bardia, A., Beelen, A., Oyekunle, T., Dell, V., Hurvitz, S.A.

Volltext

Phase II study of denileukin diftitox for previously treated low grade non-Hodgkin’s lymphoma: E1497 final report von Eklund, J. W., Weller, E., Kuzel, T. M., Foss, F., Gascoyne, R., Abramson, N., Schwerkoske, J. F., Horning, S.

Volltext

Rapid and sensitive method for the determination of salicylic acid in serum by reversed-phase ion-pair high-performance liquid chromatography von Ingalls, Stephen T., Schwerkoske, John F., Forman, Walter B., Hoppel, Charles L.

Volltext

A randomized trial of two doses of cyclophosphamide with etoposide and G-CSF for mobilization of peripheral blood stem cells in 318 patients with stage II-III breast cancer von Schwartzberg, L S, Weaver, C H, Birch, R, Manner, C, Tauer, K, Beeker, T, Morgan-Ihrig, C, MacAneny, B, Leff, R, Smith, R, Hainsworth, J, Greco, T, Schwerkoske, J, Murphy, M N, Buckner, C D

Volltext

Rapid ans sensitive method for the determination of salicylic acid in serum by reversed-phase ion-pair high-performance liquid chromatography von INGALLS, S. T, SCHWERKOSKE, J. F, FORMAN, W. B, HOPPEL, C. L

Volltext

Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572 von Schiff, David, Jaeckle, Kurt A., Anderson, S. Keith, Galanis, Evanthia, Giannini, Caterina, Buckner, Jan C., Stella, Phillip, Flynn, Patrick J., Erickson, Bradley J., Schwerkoske, John F., Kaluza, Vesna, Twohy, Erin, Dancey, Janet, Wright, John, Sarkaria, Jann N.

Volltext

Abstract 3045: Pilot study of kernel-based dynamic (KBD) FDG-PET in patients with borderline resectable pancreatic cancer von Schwerkoske, John P., Wang, Guobao, Tam, Kit W., Huynh, Jasmine C., Hunt, Heather H., Rusnak, Michael L., Foster, Cameron C., Corwin, Michael T., Matsukuma, Karen E., Gui, Dorina, Cho, May T., Bold, Richard J., Badawi, Ramsey D., Kim, Edward J.

Volltext

Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (AL... von Jaeckle, Kurt A., Anderson, S. K., Twohy, Erin L., Dixon, Jesse G., Giannini, Caterina, Jenkins, Robert, Egorin, Merrill J., Sarkaria, Jann N., Brown, Paul D., Flynn, P. J., Schwerkoske, John, Buckner, Jan C., Galanis, Evanthia

Volltext

Phase I/II Trial of Temsirolimus and Sorafenib in Treatment of Patients with Recurrent Glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572 von Schiff, David, Jaeckle, Kurt A, Anderson, S. Keith, Galanis, Evanthia, Giannini, Caterina, Buckner, Jan C., Stella, Phillip, Flynn, Patrick J, Erickson, Bradley J, Schwerkoske, John F, Kaluza, Vesna, Twohy, Erin, Dancey, Janet, Wright, John, Sarkaria, Jann N.

Volltext

Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group... von Jaeckle, Kurt A., Anderson, S. K., Twohy, Erin L., Dixon, Jesse G., Giannini, Caterina, Jenkins, Robert, Egorin, Merrill J., Sarkaria, Jann N., Brown, Paul D., Flynn, P. J., Schwerkoske, John, Buckner, Jan C., Galanis, Evanthia

Volltext

ATIM-14. ALLIANCE A071101: A PHASE II RANDOMIZED TRIAL COMPARING THE EFFICACY OF HEAT SHOCK PROTEIN PEPTIDE COMPLEX-96 (HSPPC-96) VACCINE GIVEN WITH BEVACIZUMAB VERSUS BEVACIZUMAB... von Bloch, Orin, Shi, Qian, Anderson, S Keith, Knopp, Michael, Raizer, Jeffrey, Clarke, Jennifer, Waziri, Allen, Colman, Howard, Bruce, Jeffrey, Olson, Jeffrey J, Schwerkoske, John, Parsa, Andrew, Uhm, Joon, Kumthekar, Priya, Galanis, Evanthia, Parney, Ian

Volltext

A phase II open-label trial of bortezomib in patients with multiple myeloma who have undergone an autologous peripheral blood stem cell transplant and failed to achieve a complete... von Rifkin, Robert M., Greenspan, Andrew, Schwerkoske, John F., Mandanas, Romeo A., Stephenson, Joe J., Kannarkat, George T., Zhan, Feng, Boehm, Kristi A., Asmar, Lina, Beveridge, Roy

Volltext

Phase II study of denileukin diftitox for previously treated indolent non-Hodgkin lymphoma: Final results of E1497 von Kuzel, Timothy M., Li, Shuli, Eklund, John, Foss, Francine, Gascoyne, Randy, Abramson, Neil, Schwerkoske, John F., Weller, Edie, Horning, Sandra J.

Volltext

Phase II trial of gemcitabine and docetaxel in patients with advanced carcinoma of the urothelium von Dreicer, Robert, Manola, Judith, Schneider, Daniel J., Schwerkoske, John F., George, Christopher S., Roth, Bruce J., Wilding, George

Volltext